{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T22:54:11Z","timestamp":1790204051247,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T00:00:00Z","timestamp":1772236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100021078","name":"Norwegian Institute of Public Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100021078","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Noncommunicable disease (NCD) comorbidities are common in cancer patients due to shared risk factors, but few studies have mapped their occurrence across cancer types using detailed national data. In this nationwide cohort study, we used data from Norwegian mandatory health registries to comprehensively describe NCD comorbidities at and after cancer diagnosis of 19 cancers. We included 269,956 adults registered with a first cancer in the Cancer Registry of Norway 2009\u20132019. Comorbidities included second cancers, cardiovascular diseases (CVDs), chronic obstructive pulmonary disease, diabetes and mental health disorders (MDs). We used intersection diagrams to examine NCD comorbidity patterns at first cancer diagnosis, and multi-state models to estimate five-year post-cancer probabilities of NCD comorbidities and death. We also provide a publicly available online application [\n                    <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/ncdapp.onrender.com\/\" ext-link-type=\"uri\">https:\/\/ncdapp.onrender.com\/<\/jats:ext-link>\n                    ] with additional results and details. Comorbidity prevalence at cancer diagnosis ranged from 35% (skin cancer) to 83% (lung cancer). CVD was most prevalent, usually co-occurring with MDs or diabetes. Lowest prevalences were found for younger patients and women. Conditioning on surviving five years, comorbidity probability exceeded 50% in all sites. Our findings show substantial comorbidity burden in cancer patients, varying by cancer site, age, and sex. Knowledge of these patterns could improve NCD prevention, treatment and surveillance.\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-41831-6","type":"journal-article","created":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T03:15:39Z","timestamp":1772248539000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A comprehensive nationwide registry study of noncommunicable disease comorbidities and death in cancer patients in Norway\u2014the NCDNOR project"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7976-3881","authenticated-orcid":false,"given":"Simon","family":"Lergenmuller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1652-7734","authenticated-orcid":false,"given":"Trude Eid","family":"Robsahm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3620-1555","authenticated-orcid":false,"given":"Yngvar","family":"Nilssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4401-301X","authenticated-orcid":false,"given":"Knut Eirik","family":"Dalene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9061-6869","authenticated-orcid":false,"given":"Wenche","family":"Nystad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3262-8260","authenticated-orcid":false,"given":"Haakon E.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2098-1059","authenticated-orcid":false,"given":"Hein","family":"Stigum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidar","family":"Hjellvik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2033-736X","authenticated-orcid":false,"given":"Lars J.","family":"Kjerpeseth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8529-4826","authenticated-orcid":false,"given":"Inger","family":"Ariansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9601-5324","authenticated-orcid":false,"given":"Inger Kristin","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,28]]},"reference":[{"issue":"11","key":"41831_CR1","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/S1470-2045(19)30456-5","volume":"20","author":"M Arnold","year":"2019","unstructured":"Arnold, M. et al. Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): A population-based study. Lancet Oncol. 20(11), 1493\u20131505. https:\/\/doi.org\/10.1016\/S1470-2045(19)30456-5 (2019).","journal-title":"Lancet Oncol."},{"issue":"11","key":"41831_CR2","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1080\/0284186X.2020.1822544","volume":"59","author":"FE Lundberg","year":"2020","unstructured":"Lundberg, F. E. et al. Trends in cancer survival in the Nordic countries 1990-2016: The NORDCAN survival studies. Acta Oncol. 59(11), 1266\u20131274. https:\/\/doi.org\/10.1080\/0284186X.2020.1822544 (2020).","journal-title":"Acta Oncol."},{"issue":"4","key":"41831_CR3","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3322\/caac.21342","volume":"66","author":"D Sarfati","year":"2016","unstructured":"Sarfati, D., Koczwara, B. & Jackson, C. The impact of comorbidity on cancer and its treatment. CA Cancer J. Clin. 66 (4), 337\u2013350. https:\/\/doi.org\/10.3322\/caac.21342 (2016).","journal-title":"CA Cancer J. Clin."},{"issue":"9836","key":"41831_CR4","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0140-6736(12)60240-2","volume":"380","author":"K Barnett","year":"2012","unstructured":"Barnett, K. et al. Epidemiology of multimorbidity and implications for health care, research, and medical education: A cross-sectional study. Lancet 380 (9836), 37\u201343. https:\/\/doi.org\/10.1016\/S0140-6736(12)60240-2 (2012).","journal-title":"Lancet"},{"issue":"7","key":"41831_CR5","doi-asserted-by":"publisher","first-page":"e102149","DOI":"10.1371\/journal.pone.0102149","volume":"9","author":"C Violan","year":"2014","unstructured":"Violan, C. et al. Prevalence, determinants and patterns of multimorbidity in primary care: A systematic review of observational studies. PLoS ONE 9 (7), e102149. https:\/\/doi.org\/10.1371\/journal.pone.0102149 (2014).","journal-title":"PLoS ONE"},{"issue":"9","key":"41831_CR6","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1002\/cncr.28509","volume":"120","author":"BK Edwards","year":"2014","unstructured":"Edwards, B. K. et al. Annual report to the Nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer. Cancer 120 (9), 1290\u20131314. https:\/\/doi.org\/10.1002\/cncr.28509 (2014).","journal-title":"Cancer"},{"key":"41831_CR7","unstructured":"World Health Organization. World report on ageing and health. World Health Organization. (accessed 26 September 2025); https:\/\/iris.who.int\/handle\/10665\/186463. (2015)."},{"key":"41831_CR8","unstructured":"World Health Organization. Noncommunicable diseases. (accessed 26 September 2025); https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/noncommunicable-diseases."},{"key":"41831_CR9","unstructured":"Global Burden of Disease Collaborative Network. Global burden of disease study 2021 (GBD 2021) Results. Seattle, United States: Institute for Health Metrics and Evaluation (IHME); (2021)."},{"key":"41831_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s10880-024-10011-x","author":"L Curran","year":"2024","unstructured":"Curran, L., Mahoney, A. & Hastings, B. A systematic review of trajectories of clinically relevant distress amongst adults with cancer: Course and predictors. J. Clin. Psychol. Med. Settings https:\/\/doi.org\/10.1007\/s10880-024-10011-x (2024).","journal-title":"J. Clin. Psychol. Med. Settings"},{"issue":"4","key":"41831_CR11","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1093\/annonc\/mds575","volume":"24","author":"J Walker","year":"2013","unstructured":"Walker, J. et al. Prevalence of depression in adults with cancer: A systematic review. Ann. Oncol. 24 (4), 895\u2013900. https:\/\/doi.org\/10.1093\/annonc\/mds575 (2013).","journal-title":"Ann. Oncol."},{"key":"41831_CR12","doi-asserted-by":"publisher","first-page":"k1415","DOI":"10.1136\/bmj.k1415","volume":"361","author":"A Pitman","year":"2018","unstructured":"Pitman, A., Suleman, S., Hyde, N. & Hodgkiss, A. Depression and anxiety in patients with cancer. BMJ 361, k1415. https:\/\/doi.org\/10.1136\/bmj.k1415 (2018).","journal-title":"BMJ"},{"issue":"1","key":"41831_CR13","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41572-020-0200-2","volume":"6","author":"SM Gold","year":"2020","unstructured":"Gold, S. M. et al. Comorbid depression in medical diseases. Nat. Rev. Dis. Primers 6 (1), 69. https:\/\/doi.org\/10.1038\/s41572-020-0200-2 (2020).","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"4","key":"41831_CR14","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.3892\/ol.2015.2944","volume":"9","author":"HR Smith","year":"2015","unstructured":"Smith, H. R. Depression in cancer patients: Pathogenesis, implications and treatment (review). Oncol. Lett. 9 (4), 1509\u20131514. https:\/\/doi.org\/10.3892\/ol.2015.2944 (2015).","journal-title":"Oncol. Lett."},{"issue":"1","key":"41831_CR15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2147\/CLEP.S47150","volume":"5","author":"M Sogaard","year":"2013","unstructured":"Sogaard, M., Thomsen, R. W., Bossen, K. S., Sorensen, H. T. & Norgaard, M. The impact of comorbidity on cancer survival: A review. Clin. Epidemiol. 5 (1), 3\u201329. https:\/\/doi.org\/10.2147\/CLEP.S47150 (2013).","journal-title":"Clin. Epidemiol."},{"issue":"1","key":"41831_CR16","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1186\/s12885-021-08102-1","volume":"21","author":"AP Kon\u00e9","year":"2021","unstructured":"Kon\u00e9, A. P. & Scharf, D. Prevalence of multimorbidity in adults with cancer, and associated health service utilization in Ontario, Canada: A population-based retrospective cohort study. BMC Cancer 21 (1), 406. https:\/\/doi.org\/10.1186\/s12885-021-08102-1 (2021).","journal-title":"BMC Cancer"},{"issue":"1","key":"41831_CR17","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12885-019-6472-9","volume":"20","author":"H Fowler","year":"2020","unstructured":"Fowler, H. et al. Comorbidity prevalence among cancer patients: A population-based cohort study of four cancers. BMC Cancer 20 (1), 2. https:\/\/doi.org\/10.1186\/s12885-019-6472-9 (2020).","journal-title":"BMC Cancer"},{"issue":"7","key":"41831_CR18","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1158\/0008-5472.CAN-22-1336","volume":"83","author":"CEJ Vrinzen","year":"2023","unstructured":"Vrinzen, C. E. J. et al. A systematic review and multilevel regression analysis reveals the comorbidity prevalence in cancer. Cancer Res. 83 (7), 1147\u20131157. https:\/\/doi.org\/10.1158\/0008-5472.CAN-22-1336 (2023).","journal-title":"Cancer Res."},{"key":"41831_CR19","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1186\/s12889-015-1733-2","volume":"15","author":"AP Kon\u00e9","year":"2015","unstructured":"Kon\u00e9, A. P. et al. The increasing burden and complexity of multimorbidity. BMC Public Health 15, 415. https:\/\/doi.org\/10.1186\/s12889-015-1733-2 (2015).","journal-title":"BMC Public Health"},{"key":"41831_CR20","doi-asserted-by":"publisher","first-page":"101845","DOI":"10.1016\/j.canep.2020.101845","volume":"69","author":"MM Koo","year":"2020","unstructured":"Koo, M. M. et al. The prevalence of chronic conditions in patients diagnosed with one of 29 common and rarer cancers: A cross-sectional study using primary care data. Cancer Epidemiol. 69, 101845. https:\/\/doi.org\/10.1016\/j.canep.2020.101845 (2020).","journal-title":"Cancer Epidemiol."},{"issue":"1","key":"41831_CR21","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12877-019-1173-4","volume":"19","author":"S Gontijo Guerra","year":"2019","unstructured":"Gontijo Guerra, S., Berbiche, D. & Vasiliadis, H. M. Measuring multimorbidity in older adults: Comparing different data sources. BMC Geriatr. 19 (1), 166. https:\/\/doi.org\/10.1186\/s12877-019-1173-4 (2019).","journal-title":"BMC Geriatr."},{"issue":"1","key":"41831_CR22","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/s12916-023-02970-z","volume":"21","author":"C MacRae","year":"2023","unstructured":"MacRae, C. et al. Impact of data source choice on multimorbidity measurement: A comparison study of 2.3 million individuals in the Welsh National Health Service. BMC Med. 21 (1), 309. https:\/\/doi.org\/10.1186\/s12916-023-02970-z (2023).","journal-title":"BMC Med."},{"issue":"3","key":"41831_CR23","doi-asserted-by":"publisher","first-page":"e0172814","DOI":"10.1371\/journal.pone.0172814","volume":"12","author":"C Maringe","year":"2017","unstructured":"Maringe, C., Fowler, H., Rachet, B. & Luque-Fernandez, M. A. Reproducibility, reliability and validity of population-based administrative health data for the assessment of cancer non-related comorbidities. PLoS ONE 12 (3), e0172814. https:\/\/doi.org\/10.1371\/journal.pone.0172814 (2017).","journal-title":"PLoS ONE"},{"issue":"1","key":"41831_CR24","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1186\/s12885-019-6181-4","volume":"19","author":"CL Niedzwiedz","year":"2019","unstructured":"Niedzwiedz, C. L., Knifton, L., Robb, K. A., Katikireddi, S. V. & Smith, D. J. Depression and anxiety among people living with and beyond cancer: A growing clinical and research priority. BMC Cancer 19 (1), 943. https:\/\/doi.org\/10.1186\/s12885-019-6181-4 (2019).","journal-title":"BMC Cancer"},{"issue":"9","key":"41831_CR25","first-page":"4346","volume":"13","author":"TA Ahmad","year":"2023","unstructured":"Ahmad, T. A., Gopal, D. P., Chelala, C., Dayem Ullah, A. Z. & Taylor, S. J. Multimorbidity in people living with and beyond cancer: A scoping review. Am. J. Cancer Res. 13 (9), 4346\u20134365 (2023).","journal-title":"Am. J. Cancer Res."},{"issue":"2","key":"41831_CR26","doi-asserted-by":"publisher","first-page":"880","DOI":"10.62347\/NWHM4133","volume":"14","author":"TA Ahmad","year":"2024","unstructured":"Ahmad, T. A. Prevalence of multimorbidity in survivors of 28 cancer sites: An English nationwide cross-sectional study. Am. J. Cancer Res. 14 (2), 880\u2013896. https:\/\/doi.org\/10.62347\/NWHM4133 (2024).","journal-title":"Am. J. Cancer Res."},{"issue":"10203","key":"41831_CR27","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/S0140-6736(19)31674-5","volume":"394","author":"H Strongman","year":"2019","unstructured":"Strongman, H. et al. Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: A population-based cohort study using multiple linked UK electronic health records databases. Lancet 394 (10203), 1041\u20131054. https:\/\/doi.org\/10.1016\/S0140-6736(19)31674-5 (2019).","journal-title":"Lancet"},{"key":"41831_CR28","unstructured":"Curtis R. E., et al. New Malingnancies Among Cancer Survivors: SEER Cancer Registries, 1973\u20132000. (National Cancer Institute, 2006)."},{"issue":"10","key":"41831_CR29","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1200\/JCO.2015.64.0409","volume":"34","author":"SH Armenian","year":"2016","unstructured":"Armenian, S. H. et al. Cardiovascular disease among survivors of adult-onset cancer: A community-based retrospective cohort study. J. Clin. Oncol. 34 (10), 1122\u20131130. https:\/\/doi.org\/10.1200\/JCO.2015.64.0409 (2016).","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"41831_CR30","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1001\/jamaoncol.2018.1684","volume":"4","author":"Y Hwangbo","year":"2018","unstructured":"Hwangbo, Y. et al. Incidence of diabetes after cancer development: A Korean national cohort study. JAMA Oncol. 4 (8), 1099\u20131105. https:\/\/doi.org\/10.1001\/jamaoncol.2018.1684 (2018).","journal-title":"JAMA Oncol."},{"key":"41831_CR31","doi-asserted-by":"publisher","DOI":"10.1177\/14034948231214580","author":"W Nystad","year":"2023","unstructured":"Nystad, W. et al. National health registries - a \u201cgoldmine\u201d for studying non-communicable disease occurrence in Norway - the NCDNOR project. Scand. J. Public Health. https:\/\/doi.org\/10.1177\/14034948231214580 (2023).","journal-title":"Scand. J. Public Health."},{"key":"41831_CR32","volume-title":"Cancer in Norway 2023 - Cancer incidence, mortality, survival and prevalence in Norway","author":"Cancer Registry of Norway","year":"2024","unstructured":"Cancer Registry of Norway. Cancer in Norway 2023 - Cancer incidence, mortality, survival and prevalence in Norway (Cancer Registry of Norway, 2024)."},{"issue":"1","key":"41831_CR33","doi-asserted-by":"publisher","first-page":"14479","DOI":"10.1038\/s41598-023-41660-x","volume":"13","author":"KE Dalene","year":"2023","unstructured":"Dalene, K. E. et al. Clustering and trajectories of key noncommunicable disease risk factors in Norway: The NCDNOR project. Sci. Rep. 13 (1), 14479. https:\/\/doi.org\/10.1038\/s41598-023-41660-x (2023).","journal-title":"Sci. Rep."},{"issue":"1","key":"41831_CR34","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1186\/s12889-018-5420-y","volume":"18","author":"R Hoff","year":"2018","unstructured":"Hoff, R. et al. The impact of completing upper secondary education - a multi-state model for work, education and health in young men. BMC Public Health 18 (1), 556. https:\/\/doi.org\/10.1186\/s12889-018-5420-y (2018).","journal-title":"BMC Public Health"},{"issue":"3","key":"41831_CR35","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71 (3), 209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660 (2021).","journal-title":"CA Cancer J. Clin."},{"issue":"4","key":"41831_CR36","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.15419\/bmrat.v5i4.428","volume":"5","author":"Y Khani","year":"2018","unstructured":"Khani, Y. et al. Tobacco smoking and cancer types: A review. Biomed. Res. Ther. 5 (4), 2142\u20132159. https:\/\/doi.org\/10.15419\/bmrat.v5i4.428 (2018).","journal-title":"Biomed. Res. Ther."},{"key":"41831_CR37","unstructured":"World Cancer Research Fund\/ American Institute for Cancer Research. Continuous Update Project. Diet, Nutrition, Physical Activity, and the Prevention of Cancer. Summary of Evidence. (accessed 26 September 2025); https:\/\/www.wcrf.org\/wp-content\/uploads\/2021\/01\/Matrix-for-all-cancers-A3.pdf."},{"key":"41831_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v038.i07","volume":"38","author":"LC de Wree","year":"2011","unstructured":"de Wree, L. C., Fiocco, M. & Putter, H. mstate: An R package for the analysis of competing risks and multi-state models. J. Stat. Softw. 38, 1\u201330. https:\/\/doi.org\/10.18637\/jss.v038.i07 (2011).","journal-title":"J. Stat. Softw."},{"issue":"4","key":"41831_CR39","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1093\/fampra\/cmab139","volume":"39","author":"MM Koo","year":"2022","unstructured":"Koo, M. M. et al. Morbidity and measures of the diagnostic process in primary care for patients subsequently diagnosed with cancer. Fam. Pract. 39 (4), 623\u2013632. https:\/\/doi.org\/10.1093\/fampra\/cmab139 (2022).","journal-title":"Fam. Pract."},{"issue":"9","key":"41831_CR40","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1002\/ijc.29967","volume":"138","author":"KD Skyrud","year":"2016","unstructured":"Skyrud, K. D., Bray, F., Eriksen, M. T., Nilssen, Y. & Moller, B. Regional variations in cancer survival: Impact of tumour stage, socioeconomic status, comorbidity and type of treatment in Norway. Int. J. Cancer 138 (9), 2190\u20132200. https:\/\/doi.org\/10.1002\/ijc.29967 (2016).","journal-title":"Int. J. Cancer"},{"issue":"1","key":"41831_CR41","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1186\/s12885-020-06979-y","volume":"20","author":"Y Nilssen","year":"2020","unstructured":"Nilssen, Y. et al. Patient and tumour characteristics associated with inclusion in Cancer patient pathways in Norway in 2015-2016. BMC Cancer 20 (1), 488. https:\/\/doi.org\/10.1186\/s12885-020-06979-y (2020).","journal-title":"BMC Cancer"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41831-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41831-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41831-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T09:01:26Z","timestamp":1775206886000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41831-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,28]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["41831"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-41831-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,28]]},"assertion":[{"value":"5 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11342"}}